#AgTech--Enko Chem, Inc., an AI-informed crop health company, today announced that the company has validated a unique capability to rapidly discover novel modes of action (MOA) using a systems approac...
Autore: Business Wire
MYSTIC, Conn.: #AgTech--Enko Chem, Inc., an AI-informed crop health company, today announced that the company has validated a unique capability to rapidly discover novel modes of action (MOA) using a systems approach that can effectively unlock solutions for nagging pest resistance problems for growers worldwide. New MOA’s are vital to the development of new categories of innovative, safe, pest fighting solutions.
“There are simply not enough alternatives on the market today,” says Jacqueline Heard, CEO and Co-founder, Enko. “Farmers face the harsh reality of losing 40% of their crops to weeds, insects and disease annually and are stuck using decades-old products that no longer work effectively and where continued reliance is not sustainable."
Enko’s discovery platform, ENKOMPASS™, recently identified a new mode of action, a novel weed control target, and biologically active chemical inhibitors in just 4 months using AI-assisted data analysis techniques. The capability can be applied to discover new MOAs for many crop health needs.
Enko’s rapid rate of target discovery has the potential to help the world get ahead of the rate of failing crops, stay abreast of the negative effects of climate change, and feed its growing populations safely.
About Enko®
Enko (Enko Chem Inc.) designs safe and sustainable solutions to farmers’ biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs. Founded in 2017, and led by a team of proven scientists, entrepreneurs, and agriculture industry veterans, Enko is backed by investors including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Nufarm, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund. Enko is headquartered in Mystic, Connecticut, USA. For more information, visit www.enko.ag
Enko’s Cautionary Statement Regarding Forward-Looking Statements
This press release contains forecasts, projections, goals, plans, and other forward-looking statements. Such forward-looking statements are based on Enko's assumptions, estimates, outlook, and other judgments made in light of information available at the time of preparation of such statements and involve both known and unknown risks and uncertainties. Accordingly, plans, goals, and other statements may not be realized as described, and actual financial results, success/failure or progress of development, and other projections may differ materially from those presented herein. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Enko’s control and that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Enko does not intend to update any forward-looking statements appearing herein in the event of changing circumstances or otherwise, and such statements are current only as of the date they are made.
©Enko Chem, Inc., 62 Maritime Drive, Mystic, CT 06355 USA
Fonte: Business Wire